MIAMI LAKES, Fla., Jan. 12, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) is moving originally scheduled presentation at the OneMedForum to Tues, January 13th, 2015 at 4:40 pm PST (7:40 pm EST).
A live webcast and replay of the presentation will be available on the investor relations section of the Company's corporate website, www.erbadiagnostics.com. The replay of the webcast will be archived for 90 days.
About ERBA Diagnostics, Inc.
ERBA Diagnostics, Inc. (NYSE MKT:ERB) is a fully integrated in vitro diagnostics company, offering a comprehensive suite of clinical testing products throughout the U.S. and emerging markets. The Company serves as a one-stop shop for the testing needs of the growing number of smaller hospitals, reference labs, and physician clinics. ERBA Diagnostic's line of proprietary and automated instruments, test kits, and reagents provide customers with autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. www.erbadiagnostics.com